2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Meningoencephalitis: new trials by email Literature Review of Meningoencephalitis trials Research Report on Meningoencephalitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study Placebo, EG-501 - Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE) | Phase 2 | Completed | Evergreen Therapeutics, Inc. | 131 | 2018-08-23 | 2025-12-15 |
| Treatment With Tamoxifen in Cryptococcal Meningitis Tamoxifen, Amphotericin B, Fluconazole - Meningitis Streptococcal, Hiv | Phase 2 | Completed | Oxford University Clinical Research Unit, Vietnam | 50 | 2017-10-10 | 2019-12-02 |
Acquired Immunodeficiency Syndrome (1) · Cognitive Dysfunction (1) · Cryptococcosis (1) · Lupus Erythematosus, Systemic (1) · Lupus Vasculitis, Central Nervous System (1) · Meningitis (1) · Meningitis, Cryptococcal (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Central Nervous System Infections (2) · Central Nervous System Viral Diseases (2) · Encephalitis (2) · Immune System Diseases (2) · Infections (2) · Nervous System Diseases (2) · Neuroinflammatory Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Bacterial Infections and Mycoses (1) · Blood-Borne Infections (1) · Cardiovascular Diseases (1) · Central Nervous System Fungal Infections (1)
Amphotericin B (1) · Fluconazole (1) · Tamoxifen (1)
Evergreen Therapeutics, Inc. (1) · Oxford University Clinical Research Unit, Vietnam (1)
United States (1) · Vietnam (1)
Jeremy Day, MD (1) · Leslie J. Crofford, M.D. (1)